Neogen Corporation

NasdaqGS:NEOG Stock Report

Market Cap: US$2.6b

Neogen Future Growth

Future criteria checks 3/6

Neogen is forecast to grow earnings and revenue by 86.4% and 4.3% per annum respectively while EPS is expected to grow by 86.2% per annum.

Key information

86.4%

Earnings growth rate

86.2%

EPS growth rate

Medical Equipment earnings growth16.4%
Revenue growth rate4.3%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Dec 2024

Recent future growth updates

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Apr 12
Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

Dec 03
Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

Does Neogen (NASDAQ:NEOG) Have A Healthy Balance Sheet?

Nov 07
Does Neogen (NASDAQ:NEOG) Have A Healthy Balance Sheet?

Neogen Stock: Expect Volatility To Continue Amid Weak Growth

Oct 11

Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

Aug 28
Risks To Shareholder Returns Are Elevated At These Prices For Neogen Corporation (NASDAQ:NEOG)

We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt

Jul 31
We Think Neogen (NASDAQ:NEOG) Is Taking Some Risk With Its Debt

Neogen Corporation: Challenges Remain

Jun 26

There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price

May 21
There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price

Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust

Apr 15

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Apr 12
Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Mar 29
Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Neogen: All About Execution From Here On

Mar 26

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Jan 17
Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jan 12
Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Jan 09
Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Dec 06
Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Jul 12
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Jun 20
Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Mar 25
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use

Oct 10

Neogen GAAP EPS of $0.05, revenue of $132.35M

Sep 27

Neogen drops 9% as merger with 3M’s food safety business closes

Sep 01

Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Aug 21
Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Neogen: Cut In Half, Still Some Questions

Aug 12

There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Aug 04
There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Neogen: Thesis Unchanged After Q4 And Full-Year Earnings

Aug 01

Neogen FQ4 2022 Earnings Preview

Jul 25

Zoetis, IDEXX named as buys in animal health space by Piper Sandler

Jul 13

Neogen announces pricing of $350M senior notes offering

Jul 07

Earnings and Revenue Growth Forecasts

NasdaqGS:NEOG - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
5/31/20271,02827N/A1553
5/31/202698212N/A1423
5/31/2025936-6N/A1243
8/31/2024912-24-125-6N/A
5/31/2024924-9-7635N/A
2/29/20249292-1399N/A
11/30/20239191217113N/A
8/31/2023919-27-578N/A
5/31/2023822-23-2541N/A
2/28/2023721-13-82-30N/A
11/30/2022631-16-50-6N/A
8/31/202253136-531N/A
5/31/2022527484468N/A
2/28/2022514495070N/A
11/30/2021503575475N/A
8/31/2021487625579N/A
5/31/2021468615481N/A
2/28/2021450615885N/A
11/30/2020433607193N/A
8/31/2020426616587N/A
5/31/2020418596286N/A
2/29/2020419596281N/A
11/30/2019417605172N/A
8/31/2019416605271N/A
5/31/2019414604964N/A
2/28/2019413624966N/A
11/30/2018410655774N/A
8/31/2018403664867N/A
5/31/201839863N/A69N/A
2/28/201838958N/A62N/A
11/30/201738252N/A58N/A
8/31/201737246N/A59N/A
5/31/201735844N/A60N/A
2/28/201735341N/A53N/A
11/30/201634139N/A44N/A
8/31/201633037N/A49N/A
5/31/201632137N/A35N/A
2/29/201631036N/A38N/A
11/30/201530135N/A41N/A
8/31/201529034N/A40N/A
5/31/201528334N/A44N/A
2/28/201527232N/A38N/A
11/30/201426531N/A34N/A
8/31/201425629N/A27N/A
5/31/201424728N/A22N/A
2/28/201423628N/A24N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NEOG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: NEOG is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: NEOG is expected to become profitable in the next 3 years.

Revenue vs Market: NEOG's revenue (4.3% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: NEOG's revenue (4.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NEOG's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 23:42
End of Day Share Price 2025/01/02 00:00
Earnings2024/08/31
Annual Earnings2024/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Neogen Corporation is covered by 18 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David WestenbergCL King & Associates, Inc.
Steven CrowleyCraig-Hallum Capital Group LLC
Paul KnightCredit Agricole Securities (USA) Inc.